Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Brexpiprazole is indicated in adult patients for: Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD). Efficacy was demonstrated in 6-week trials in adults with MDD who had an inadequate response to antidepressant therapy during the current episode. The long-term efficacy of brexpiprazole as adjunctive treatment in MDD has not been established.
Treatment of schizophrenia.
Treatment of agitation associated with Alzheimer's dementia (AAD).
Limitations of Use: REXULTI is not indicated as an as needed ("prn") treatment for agitation associated with dementia due to Alzheimer's disease.

Rexulti Indications/Uses

brexpiprazole

Manufacturer:

Lundbeck

Distributor:

Zuellig Pharma